Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Bronchopulmonary Dysplasia

1-anilino-8-naphthalenesulfonate has been researched along with Bronchopulmonary Dysplasia in 1 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boehm, G1
Bierbach, U1
Moro, G1
Minoli, I1

Other Studies

1 other study available for 1-anilino-8-naphthalenesulfonate and Bronchopulmonary Dysplasia

ArticleYear
Limited fat digestion in infants with bronchopulmonary dysplasia.
    Journal of pediatric gastroenterology and nutrition, 1996, Volume: 22, Issue:2

    Topics: Bile Acids and Salts; Bronchopulmonary Dysplasia; Dietary Fats; Duodenum; Feces; Female; Humans; Hya

1996